Specifically, cfAFP-DNA expression was superior at discriminating HCC patients from LC, LA, and HD cohorts compared to other serum enzymes, including AFP, AST, ALT, albumin, ALP, and bilirubin. Here, AFP is linked to hepatocellular carcinoma.